Non-Small Cell Lung Cancer, Version 4.2024

被引：108

作者：

Riely, Gregory J. ^{[1
]}

Wood, Douglas E. ^{[2
]}

Ettinger, David S. ^{[3
]}

Aisner, Dara L. ^{[4
]}

Akerley, Wallace ^{[5
]}

Bauman, Jessica R. ^{[6
]}

Bharat, Ankit ^{[7
]}

Bruno, Debora S. ^{[8
]}

Chang, Joe Y. ^{[9
]}

Chirieac, Lucian R. ^{[10
]}

Decamp, Malcolm ^{[1
,11
]}

Desai, Aakash P. ^{[1
,2
,12
]}

Dilling, Thomas J. ^{[1
,3
,13
]}

Dowell, Jonathan ^{[1
,4
,14
]}

Durm, Gregory A. ^{[1
,5
,15
]}

Gettinger, Scott ^{[1
,6
,16
]}

Grotz, Travis E. ^{[1
,7
,17
]}

Gubens, Matthew A. ^{[1
,8
,18
]}

Juloori, Aditya ^{[1
,9
,19
]}

Lackner, Rudy P. ^{[2
,20
]}

Lanuti, Michael ^{[1
,2
,21
]}

Lin, Jules ^{[2
,22
]}

Loo, Billy W., Jr. ^{[2
,3
,23
]}

Lovly, Christine M. ^{[2
,4
,24
]}

Maldonado, Fabien ^{[2
,4
,24
]}

Massarelli, Erminia ^{[2
,5
,25
]}

Morgensztern, Daniel ^{[2
,6
,26
]}

Mullikin, Trey C. ^{[2
,7
,27
]}

Ng, Thomas ^{[2
,8
,28
]}

Owen, Dawn ^{[1
,7
,17
]}

Owen, Dwight H. ^{[2
,9
,29
]}

Patel, Sandip P. ^{[3
,30
]}

Patil, Tejas ^{[4
]}

Polanco, Patricio M. ^{[1
,4
,14
]}

Riess, Jonathan ^{[1
,3
,31
]}

Shapiro, Theresa A. ^{[3
]}

Singh, Aditi P. ^{[2
,3
,32
]}

Stevenson, James ^{[8
]}

Tam, Alda ^{[9
]}

Tanvetyanon, Tawee ^{[1
,3
,13
]}

Yanagawa, Jane ^{[3
,33
]}

Yang, Stephen C. ^{[3
]}

Yau, Edwin ^{[3
,4
,34
]}

Gregory, Kristina M. ^{[35
]}

Hang, Lisa ^{[3
,5
,35
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA

[2] Fred Hutchinson Canc Ctr, Sunnyside, WA USA

[3] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Mcadoo, PA USA

[4] Univ Colorado, Ctr Canc, Denver, CO 80202 USA

[5] Univ Utah, Huntsman Canc Inst, Biol, Salt Lake City, UT USA

[6] Fox Chase Canc Ctr, Oreland, PA USA

[7] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[8] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[9] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[10] Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA

[11] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA

[12] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[13] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[14] UT Southwestern, Simmons Comprehens Canc Ctr, Dallas, TX USA

[15] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN USA

[16] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[17] Mayo Clin, Mayo Clin Comprehens Canc Ctr, Dept Canc Biol, Jacksonville, FL 32224 USA

[18] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[19] UChicago Med Comprehens Canc Ctr, Maywood, IL USA

[20] Fred & Pamela Buffett Canc Ctr, Clin Infus Ctr, Omaha, NE 68105 USA

[21] Mass Gen Canc Ctr, Waltham, MA USA

[22] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA

[23] Stanford Canc Inst, Stanford, CA USA

[24] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Med Ctr, Vanderbilt, TN 37232 USA

[25] City Hope Natl Med Ctr, Monrovia, CA USA

[26] Washington Univ Sch Med, Barnes Jewish Hosp, Siteman Canc Ctr, Washington, DC USA

[27] Duke Univ, Duke Canc Inst, Durham, NC USA

[28] Univ Tennessee, Hlth Sci Ctr, Bartlett, TN USA

[29] Ohio State Univ, Solove Res Inst, James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA

[30] UC San Diego Moores Canc Ctr, San Diego, CA USA

[31] Uc Davis Comprehens Canc Ctr, Davis, AL USA

[32] Univ Penn, Abramson Canc Ctr, Ctr CLL, Philadelphia, PA USA

[33] UCLA Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[34] Roswell Pk Comprehens Canc Ctr, Biostat, Buffalo, NY USA

[35] Natl Comprehens Canc Network, Rockledge, PA 19111 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2024年 / 22卷 / 04期

关键词：

GROWTH-FACTOR-RECEPTOR; UNCOMMON EGFR MUTATIONS; TYROSINE-KINASE INHIBITOR; EXON; 20; INSERTION; DABRAFENIB PLUS TRAMETINIB; POST-HOC ANALYSIS; OPEN-LABEL; CLINICAL ACTIVITY; NEVER SMOKERS; ACQUIRED-RESISTANCE;

D O I：

10.6004/jnccn.2204.0023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC, including diagnosis, primary disease management, surveillance for relapse, and subsequent treatment. The panel has updated the list of recommended targeted therapies based on recent FDA approvals and clinical data. This selection from the NCCN Guidelines for NSCLC focuses on treatment recommendations for advanced or metastatic NSCLC with actionable molecular biomarkers.

引用

页码：249 / 274

页数：26

共 50 条

[31] Continuing EGFR inhibition beyond progression in advanced non-small cell lung cancer
Yap, Timothy A.
Macklin-Doherty, Aislinn
Popat, Sanjay
EUROPEAN JOURNAL OF CANCER, 2017, 70 : 12 - 21
[32] Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake
De Toma, Alessandro
Lo Russo, Giuseppe
Signorelli, Diego
Pagani, Filippo
Randon, Giovanni
Galli, Giulia
Prelaj, Arsela
Ferrara, Roberto
Proto, Claudia
Ganzinelli, Monica
Zilembo, Nicoletta
de Braud, Filippo
Garassino, Marina Chiara
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 160
[33] Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives
Zhang, Hang
Zhang, Yingying
Zhu, Yingying
Dong, Tian
Liu, Zheng
FRONTIERS IN ONCOLOGY, 2024, 14
[34] Non-Small Cell Lung Cancer
Ettinger, David S.
Akerley, Wallace
Borghaei, Hossein
Chang, Andrew C.
Cheney, Richard T.
Chirieac, Lucian R.
D'Amico, Thomas A.
Demmy, Todd L.
Ganti, Apar Kishor P.
Govindan, Ramaswamy
Grannis, Frederic W., Jr.
Horn, Leora
Jahan, Thierry M.
Jahanzeb, Mohammad
Kessinger, Anne
Komaki, Ritsuko
Kong, Feng-Ming
Kris, Mark G.
Krug, Lee M.
Lennes, Inga T.
Loo, Billy W., Jr.
Martins, Renato
O'Malley, Janis
Osarogiagbon, Raymond U.
Otterson, Gregory A.
Patel, Jyoti D.
Pinder-Schenck, Mary C.
Pisters, Katherine M.
Reckamp, Karen
Riely, Gregory J.
Rohren, Eric
Swanson, Scott J.
Wood, Douglas E.
Yang, Stephen C.
Hughes, Miranda
Gregory, Kristina M.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (10): : 1236 - 1271
[35] Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer
Bar, Jair
Ofek, Efrat
Barshack, Iris
Gottfried, Teodor
Zadok, Oranit
Kamer, Iris
Urban, Damien
Perelman, Marina
Onn, Amir
LUNG CANCER, 2019, 138 : 109 - 115
[36] Personalizing Therapy with Targeted Agents in Non-Small Cell Lung Cancer
Dienstmann, Rodrigo
Martinez, Pablo
Felip, Enriqueta
ONCOTARGET, 2011, 2 (03) : 165 - 177
[37] Impact of EGFR mutation analysis in non-small cell lung cancer
Yamamoto, Hiromasa
Toyooka, Shinichi
Mitsudomi, Tetsuya
LUNG CANCER, 2009, 63 (03) : 315 - 321
[38] Molecular Pathology of Non-Small Cell Lung Cancer A Practical Guide
Aisner, Dara L.
Marshall, Carrie B.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (03) : 332 - 346
[39] Novel agents in development for advanced non-small cell lung cancer
Stinchcombe, Thomas E.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2014, 6 (05) : 240 - 253
[40] Targeted Therapies for Non-Small Cell Lung Cancer: An Evolving Landscape
Pal, Sumanta Kumar
Figlin, Robert A.
Reckamp, Karen
MOLECULAR CANCER THERAPEUTICS, 2010, 9 (07) : 1931 - 1944

← 1 2 3 4 5 →